Millie
your market intelligence analyst
Search Results
331 results
Your search is now limited to «AstraZeneca» expert search.
ENDPOINTS 12/10/2019 11:09
AstraZeneca is aligning itself with the big data company DeepMatter, which is focused on attaining reproducibility in chemistry.
More from ENDPOINTS:
Xconomy 12/09/2019 07:35
After joining AstraZeneca’s Boston Bio Hub incubator last year, Gatehouse Bio is now teaming up with the pharma company to identify potential drug targets in respiratory and cardiovascular diseases.
More from Xconomy:
Pharmafile 12/09/2019 06:48
AstraZeneca’s trial of leukaemia drug Calquence yields positive results.
More from Pharmafile:
FiercePharmaManufacturing 12/08/2019 00:06
I think that that landmark data is really very important and very impressive,” Dave Fredrickson, EVP and global head of AstraZeneca’s oncology business unit, said.
More from FiercePharmaManufacturing:
NASDAQ 12/06/2019 09:22
This year so far, AstraZeneca’s shares have risen 25.3% compared with the industry’s growth of 6.9.
More from NASDAQ:
Gatehouse Bio collaborates with AstraZeneca to accelerate new drug discovery.
More from Pharmaceutical Business Review:
ETHealthWorld (India) 12/05/2019 04:32
AstraZeneca-Merck Lynparza wins approval in China for ovarian cancer treatment, Health News, ET HealthWorld.
More from ETHealthWorld (India):
Reuters.com 12/05/2019 03:40
AstraZeneca-Merck Lynparza wins approval in China for ovarian cancer treatment.
More from Reuters.com:
Updated Date: Thu, 05 Dec 2019 00:00:00 EST.
More from National Library of Medicine - DailyMed Drug Label Updates (NLM):
World Pharma News 12/03/2019 04:00
AstraZeneca has agreed to sell the commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release) in the US and Canada to Cheplapharm Arzneimittel GmbH (Cheplapharm.
More from World Pharma News:
Business Standard (India) 12/02/2019 02:12
Pfizer, Sanofi India, AstraZeneca hit new high.
More from Business Standard (India):
Channel NewsAsia (Singapore) 11/29/2019 03:35
AstraZeneca's Imfinzi gets speedy FDA review for small cell lung cancer.
More from Channel NewsAsia (Singapore):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications